研究含有胺基生物异构体的Hsp90C-终端抑制剂

Eva Amatya1, Chitra Subramanian2, Reagan Long1

  • 1Department of Chemistry and Biochemistry, Warren Family Research Center for Drug Discovery and Development, University of Notre Dame, Notre Dame, Indiana, 46556, USA.

ChemMedChem
|August 17, 2024
PubMed
概括

研究人员开发了用于治疗黑色素瘤的新型热冲击蛋白90 (Hsp90) C终端抑制剂. 这些化合物对突变和野生型BRAF黑色素瘤细胞都表现出抗增殖活性,这表明它们具有治疗潜力.